Defining and Describing Benefit Appropriately in Clinical Trials


  • Nancy M. P. King

    1. Professor of Social Medicine at the University of North Carolina School of Medicine in Chapel Hill. She teaches legal, social, and ethical issues tomedical students as part of the comprehensive social medicine curriculum at UNC. She has worked extensively on issues related to informed consent in health care and research, the development and use of experimental technologies, and decision-making at the end oflife. She is co-editor, with two UNC colleagues, of Beyond Regulations: Ethics in HumanSubjects Research (UNC Press 1999), and a member of the Recombinant DNA Advisory Committee of the National Institutes of Health. She received a B.A. from St. John's College in Annapolis, Maryland, and her J.D. from UNC School of Law.
    Search for more papers by this author